Status:
COMPLETED
Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease
Lead Sponsor:
Kyowa Kirin Co., Ltd.
Conditions:
End Stage Renal Disease
Hyperparathyroidism, Secondary
Eligibility:
All Genders
Brief Summary
The MBD-5D is a prospective observational study with a case-cohort and a cohort design. Eligible patients are receiving hemodialysis and have secondary hyperparathyroidism. The study's three goals are...
Detailed Description
The MBD-5D is a 3-year prospective observational study with a case-cohort and a cohort design. Eligible patients comprise all patients who are receiving hemodialysis at the participating facilities, a...
Eligibility Criteria
Inclusion
- patients receiving hemodialysis
- patients whose intact PTH concentration is at least 180 pg/mL (106 pg/mL for whole PTH) OR patients who are receiving intravenous active vitamin D sterols or oral active vitamin D sterols (falecalcitriol)
Exclusion
- patients have been undergoing hemodialysis for less than 3 months
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
8020 Patients enrolled
Trial Details
Trial ID
NCT00995163
Start Date
January 1 2008
End Date
January 1 2011
Last Update
August 23 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kobe, Japan